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Summary
Introduction: Based on recent analyses, the measures of short-term responsiveness of magnetic resonance imaging (MRI) derived cartilage
morphometry may not be as large as earlier studies had suggested. We examined if by selecting regions of interest with denuded cartilage, the
remaining cartilage within this region of interest was susceptible to greater rates of cartilage loss.
Methods: Subjects included for this analysis are a subset of the approximately 4700 participants in the Osteoarthritis Initiative (OAI) Study.
Bilateral radiographs and 3 T MRI (Siemens Trio) of the knees and clinical data are obtained at baseline and annually in all participants. Hun-
dred and ﬁfty subjects from the OAI progression subcohort all of whom had both frequent symptoms and, in the same knee, radiographic os-
teoarthritis (ROA deﬁned as deﬁnite tibio-femoral osteophytes on X-ray) based on a screening reading done at the OAI clinics. One knee from
each subject was selected for analysis. Using sagittal 3D DESSwe MR images from the baseline and 12-month follow-up visit, a segmentation
algorithm was applied to the cartilage plates of the index knee to compute the cartilage volume, normalized cartilage volume (volume normal-
ized to bone surface interface area), and percent denuded area (Total Cartilage Bone Interface area denuded of cartilage). Summary statistics
of the changes (absolute and percentage) from baseline at 1 year and the standardized response mean (SRM), i.e., mean change divided by
the standard deviation (SD) of that change were calculated. Analyses are stratiﬁed into three groups according to baseline assessment of
denuded area: those with no denuded area in the region of interest at baseline, and then two groups (intermediate denuded area (median)
and severe (median) denuded area) of equal sample size.
Results: On average the subjects were 60.9 years of age and obese with a mean body mass index (BMI) of 30.3 kg/m2. For the combined
central medial femur and tibia the mean volume change for the whole sample was 48.2 (SD 159.8) mm3, which gives an SRM of 0.30.
In the subsample of knees with no denuded area the SRM was 0.25, in the knees with intermediate denuded area the SRM was 0.30,
and in knees with severe denuded area the SRM was 1.00. For normalized volume of the central medial femur in the subsample of knees
with no denuded area the SRM was 0.22, in the knees with intermediate denuded area the SRM was 0.26, and in knees with severe de-
nuded area (n¼ 23) the SRM was 0.71. The magnitude of the SRMs was generally smaller in participants with no denuded area. In contrast,
the SRMs in participants with denuded area were larger.
Conclusion: By selecting participants with the presence of cartilage regions with denuded area the ability to demonstrate change in cartilage
loss in that speciﬁc location is markedly improved compared to persons without a full thickness lesion in that cartilage plate. This option for
screening during recruitment in clinical trials could facilitate the detection of participants at greater risk of subsequent cartilage loss.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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175options are limited to symptomatic treatment. Development
of therapies aimed at joint preservation in OA is constrained
by the relatively slow progress of the condition, its heteroge-
neous clinical manifestations, the ideal to expose patients to
an unknown drug for as short a period as possible and the cur-
rent need for long-term follow-up to observe changes in
structure.
It is hoped that new technologiesmay improve the assess-
ment of early disease development, and progression, and
could greatly facilitate measurement of structural outcomes
in OA clinical trials. Foremost among the potential imaging
176 D. J. Hunter et al.: Region of interest analysistechniques ismagnetic resonance imaging (MRI), a sensitive
non-invasive method for assessing joint morphology1.
There is a signiﬁcant body of supporting data on the longitu-
dinal change in cartilage volume as a responsive primary end-
point to reﬂect OA progression1. It is further claimed that MR
images offer a more sensitive measure of OA and its progres-
sion than X-ray2. Early longitudinal studies suggested that
changes of cartilage volume of the order of 4% to 6% (SD
ofw5%) occur per annum in OA in most knee compartments
followed for periods up to 3 years1. The annual changes in car-
tilagevolumeexceeded theprecisionerrorsandappeared tobe
associated with clinical symptoms as well as with time to knee
arthroplasty3,4. Highlighting data from two of these prior studies
the annualized data from Cicuttini et al 5 demonstrate that the
medial femoral standardized response mean (SRM) is 0.50
and the medial tibial SRM is 0.4. The data from Pelletier et al 6
show the medial femoral SRM is 1.1 and the medial tibial
SRM is 1.1 over 24 months. However, based on more recent
analyses the responsiveness of MRI derived parameters may
not be as good as earlier studies had suggested7,8.
The more recent studies using similar cartilage quantiﬁ-
cation techniques demonstrate cartilage volume loss of
about 1 to 3% per year8e12. The SRMs are essentially
consistent between these studies with a maximum SRM
of w0.4. Like the prior studies the measurement variance
was of similar magnitude to the rate of change. Thus, these
more conservative recent estimates have important implica-
tions for planning of future clinical trials of disease modifying
treatments for OA using MRI techniques.
Using these conservative estimates for power calculation,
studydesignsbasedon largeMRIprogressionseries currently
in the public domain require largesample sizes if oneuses car-
tilage volumeas the endpoint. It is obviously preferable to con-
ﬁdently design studies based on smaller sample sizes and/or
shorter study durations, as this would reduce the resource im-
plications for MRI based interventional studies.
Several studies have suggested that baseline clinical, bio-
marker, and imaging features are predictive of progression of
cartilage loss in the medial compartment of the knee and
could be used to provide greater study power by selecting
a population at greater risk formore rapid progression. These
include increased body mass index (BMI)13, an increased
level of type II collagen C-terminal degradation products de-
tected in the urine (uCTX-II)14, the presence of varus mal-
alignment at the tibio-femoral joint10,11,15, the presence on
MRI of subchondral bone marrow lesions16 or meniscal ab-
normalities17. If the more conservative estimates of progres-
sion are real it will become more important to identify
populations within this at greatest risk for progression.
Prior studies have also suggested that the presence of
semi-quantitative cartilage defects may predict subsequent
cartilage volume change18e20. The objective of this analysis
was to ascertain if by selecting regions of interest with pres-
ence of denuded cartilage measured quantitatively, the
remaining cartilage within this region of interest was sus-
ceptible to greater rate of change in cartilage morphometry
measures from baseline to 1 year in knees with OA from
a subset of participants from the Osteoarthritis Initiative
(OAI) progression subcohort.Materials and methodsSTUDY SAMPLESubjects included for this analysis are a subset of the 4796 participants par-
ticipating in theOAIStudy,which is anongoing4-year,multi-center, longitudinal,
prospective observational cohort study, focusing primarily on knee OA. The
study protocol, amendments, and informed consent documentation werereviewed and approved by the local institutional review boards. Data used in
the preparation of this manuscript were obtained from the OAI database, which
is available for public access at http://www.oai.ucsf.edu. The speciﬁc datasets
used are clinical data set 0.1.1 and Image Release 0.B.1 and 1.B.1.
OAI consists of two subcohorts: a Progression subcohort, and an Inci-
dence subcohort. Two different populations of subjects were recruited;
1389 patients with radiographic evidence and symptoms of knee OA at base-
line were recruited into the Progression subcohort and another group with
risk factors for the development of symptomatic knee OA was recruited to
the Incidence subcohort. All of the participants for the present study were
drawn from the Progression subcohort.
The inclusion criteria for the Progression subcohort of the OAI required
that both of the following criteria must be present together in at least one
knee at baseline:
1. Frequent knee symptoms, deﬁned as pain, aching or stiffness on most
days of a month during the past year,
2. Radiographic evidence of OA (ROA) deﬁned as deﬁnite tibio-femoral os-
teophytes (OARSI atlas grade1) onX-ray. Subjectswith severe narrow-
ing (OARSI grade 3 narrowing or bone on bone) in both knees were
planned to be excluded. The grading of osteophytes and joint space nar-
rowing (JSN) was done at each individual OAI enrollment center.
The participants consisted of the ﬁrst substantive data release from the
OAI progression subcohort. These were selected by OAI from participants
who had complete baseline and 1 year MRI data in early 2006, with blocking
for sex and center. This was a convenience sample of subjects. The ultimate
selection of participants and radiographic results in this study are based
upon central radiographic readings.RADIOGRAPHIC ASSESSMENTBilateral posteroanterior (PA) views were obtained using a SynaFlexer
frame (Synarc, Inc., San Francisco, CA) to position the subject’s feet reproduc-
ibly21. Baseline and follow-up radiographs of the sample of 160 subjects were
read independently by two study readers, one abone and joint radiologist (PA),
and the other a rheumatologist David JHunter (DJH). KneeX-rayswere read in
a paired fashion, blinded to sequence. The two central readers (DJH and PA)
separately evaluated the Kellgren & Lawrence grade (KeL) (0e4 scale)22 as
well as individual radiographic features23, i.e., osteophytes and JSN on a 0e3
scale of each knee at both time points using the Osteoarthritis Research
Society International (OARSI) atlas. For the KeL grade we used adjudicated
readings that were arrived at by a consensus of both readers at a later reading
session, with both readers and an adjudicator present. Disagreements on JSN
were also adjudicated if the two readers disagreed.SELECTION OF KNEE FOR ANALYSISBilateral MRIs from 160 participants were provided byOAI but only one knee
from 150 patients (one knee per subject) was identiﬁed for analysis. The ratio-
nale for reducing the sample from 160 to 150was that the budget for processing
the imageswas limited and in additionwewanted to optimize the use of subjects
more likely to progress. The selection of the index knee for this analysis was
based on the presence of both symptoms (frequent knee pain) and ROA in
the same knee. One hundred patients had unilateral symptomatic ROA, and
this knee was chosen for analysis, regardless of radiographic severity. For the
remaining participants with bilateral symptomatic ROA one knee was selected,
favoring the knee with moderate disease more likely to undergo disease pro-
gression (for further details on knee selection see prior publication8).MRI SEQUENCE PARAMETERSImages were acquired on a 3 T MRI scanner (Siemens Magnetom Trio,
Erlangen, Germany) with a quadrature transmitereceive knee coil (USA In-
struments, Aurora, OH). For the purposes of cartilage segmentation we
used the sagittal 3D DESSwe images with a slice thickness of 0.7 mm,
16.3 ms Repetition time (TR), 4.7 ms Echo Time (TE), 25 Flip angle (FA),
160 slices, 140 mm Field of View (FOV); 384 307 matrix; in-plane resolu-
tion 0.37 0.46 mm (interpolated to an isotropic in-plane resolution of
0.37 0.37 mm), 185 Hz/pixel bandwidth, 0% phase oversampling, 10%
slice oversampling, 80% phase resolution, 100% slice resolution, one aver-
age, elliptical ﬁlter on, asymmetric echo off, anterior/posterior phase encod-
ing, fast gradient and fast radiofrequency (RF) options (acquisition time
10 min 23 s).MRI POST PROCESSINGThe cartilage segmentation was done using Double Echo Steady State
(DESS) MRI sagittal sequences acquired by the OAI. The DESS sequence
provides a complete high-resolution view of the knee cartilage tissue with
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tissue. The segmentation was done by VirtualScopics analysis methods
and proprietary software24,25. The cartilage segmentation software of one
of the time points was based on a knowledge based 3D deformable model
of the cartilage tissue that adjusts its boundaries automatically until it
matches the underlying image cartilage tissue. Then those segmentations
were supervised and errors were corrected by trained technicians using Vir-
tualScopics software, and inspected by an expert musculoskeletal radiologist
(ST). Once segmentation was completed in one of the time points, the sec-
ond time point was segmented by tracking that segmentation into the second
time point. Once it was tracked, the tracked segmentation was again super-
vised and segmentation error was corrected by trained technicians and the
ﬁnal segmentation supervised by an expert musculoskeletal radiologist. Im-
age pairs were blinded to time point (baseline or 1 year).
After image segmentation, the following measures were analyzed in the
regions depicted in Fig. 1:
1. Cartilage volume.
2. Normalized cartilage volume (volume normalized to bone surface inter-
face area). The bone surface interface area is the area of the cartilage
in contact with bone. The normalization was done by dividing the mea-
sured cartilage volume by the area of measured cartilage in contact
with bone plus the area of full thickness defects (denuded area of
bone). Because normal knee cartilage is a thin tissue with a large
area, the normalized volume is an equivalent measurement of the car-
tilage thickness for cartilage areas with no full thickness defects. Full
thickness defects will reduce the cartilage volume but they will not af-
fect the intact cartilage area that is used to compute the normalized vol-
ume values.
3. Denuded area (Total Cartilage Bone Interface area denuded of carti-
lage). The denuded area is the area of bone where a full thickness car-
tilage defect is present (see Fig. 2).
A trimming algorithm that removes cartilage tissue outside of a 1 mm thick
boundary region was used to reduce the variability in the deﬁnition of cartilage
tissue (see Fig. 3). The trimming algorithm worked by doing a 3D rendering of
the baseline segmentation of bone and cartilage tissue, and then doingFig. 1. MRI slices and schematics depicting cartilage regions. Top panel L
Medial sagittal depiction of femoral and tibial regions. Lower panel. Corona mathematical morphology dilatation operation on the bone tissue not-cov-
ered with cartilage or denuded areas. The dilated bone was used to estimate
a 3D region that included 1.0 mm of boundary cartilage tissue. The new 3D re-
gion was used to remove the boundary tissue at the baseline and then the
same region was used to remove the same amount in the follow-up observa-
tion. Because the trimmed algorithm only removed cartilage tissue, the deﬁni-
tion of denuded areaswas not affected by the trimming algorithm. The trimmed
results are presented for each cartilage morphometry biomarker.STATISTICAL ANALYSISThe objective of this analysis was to assess, in subjects with knee OA, the
rate of natural progression of the disease. The measures of rate of progres-
sion included the change and percent change from baseline to 1 year in the
regular (non-normalized) cartilage volume, as well as change and percent
change of normalized cartilage volume within regions of the knee stratiﬁed
by extent of denuded surface area. Due to patients being observed at vari-
able follow-up times at 1 year (the range of interval between baseline and
1 year follow-up visit was 335e546 days), changes from baseline were an-
nualized assuming a linear trend over time.
To control for possible image analysis biases, image pairs were random-
ized in a 1:1 ratio using a block randomization scheme to two different paired
image analysis scenarios: baseline supervised segmentation followed by
a computer-based tracked segmentation of the 1 year follow-up (denoted
by workﬂow A) or 1 year supervised segmentation followed by a computer-
based tracked segmentation of the baseline MRI (denoted by workﬂow B).
Due to differences in image analysis workﬂow, annual decreases in thick-
ness and volume in workﬂow A were smaller than that in workﬂow B, sug-
gesting that there is a systematic bias in estimating annual change.
We developed a statistical model to estimate such bias when calculating
the annual change using the following formula:
Annual rate of changei ¼ ai þ bi Workflow
where workﬂow A that is supervised segmentation at baseline is denoted as
1; workﬂow B that is tracked segmentation at baseline is denoted as 1.ateral sagittal depiction of femoral and tibial regions. Middle panel.
al depiction of femoral and tibial regions including notch and spine.
Fig. 2. Figure depicting denuded areas from a representative DESS image. The denuded areas are computed from the 3D rendering
of the knee bones. The distal femur is displayed showing the denuded areas in red and the cartilage bone interface in grey
(courtesy of VirtualScopics).
Fig. 3. Trimming. The computer automatically creates an edge template to consistently remove from both time points at most 1.0 mm from the
edges of the cartilage tissue. Top, the red contours represent the cartilage tissue removed from the segmentation map. Bottom, 3D rendering
of the removed tissue overplayed on top the 3D rendering of the femoral cartilage.
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and the correction factor is the bi coefﬁcient. The bi value is then used to cor-
rect all the observed values.
For each affected endpoint, the magnitude of bias, bi, was estimated and
used to obtain corrected (unbiased) measurements of change from baseline.
These corrections were applied to the whole sample, and they rely on the
reasonable assumption that the randomization was effective.
From the bias-corrected dataset, summary statistics of the changes (abso-
lute and percentage) from baseline at 1 year and the SRM, i.e., mean change
divided by the SD change were calculated. The baseline values, annualized
mean change, and annualized percent change are each displayed. Analyses
are stratiﬁed into three groups according to baseline assessment of denuded
area: those with no denuded area in the region of interest at baseline, and
then two groups (intermediate denuded area (median) and severe denuded
area (>median)) of equal sample size. The number of participants with de-
nuded area was deﬁned by cartilage plate and thus can differ between the car-
tilage plates. To compare the signiﬁcance of the differences between the
denuded area strata, we have used a one way analysis of variance (ANOVA)
to test the difference in the annualized mean change of (normalized) cartilage
volume trimmed among three groups of denuded surface area. Multiple com-
parisons with adjusted Tukey method were further performed. The denuded
area variables were not normally distributed with a large number of values at
both baseline and year one equal to zero. There were only 11 participants
with denuded area in the posterior lateral femur so data from this region is
not shown. All statistics were computed using SAS 9.0.Results
On average the 150 subjects were 60.9 years of age and
obese with a mean BMI of 30.3 kg/m2. Approximately half
(51%) of the study sample were female, as designed in
the OAI protocol. Sixteen percent of the study sample did
not have radiographic tibiofemoral (TF) OA using the com-
monly accepted criteria of KeL grade 2. This circum-
stance arose because eligibility into the OAI progression
subcohort was based on the identiﬁcation of a deﬁnite ti-
bio-femoral osteophyte by the individual OAI enrollment
center and some disagreement in radiographic assessment
with the adjudicated scoring occurred. Further demographic
characteristics are available in the original publication8.
The prevalence and size of denuded area at baseline by
anatomic region of the knee in these participants are dis-
played in Table I. At baseline denuded area lesions were
more prevalent in the whole femur (47% of participants),
central weight bearing portion of the medial femur (37%),
and patella (39%).
The rate of natural progression of the disease asmeasured
by the change in the regular (non-normalized) cartilage vol-
ume and normalized cartilage volume over a period of 1
year within regions of the knee is depicted in Tables II and
III. The magnitude of change was further stratiﬁed by the ex-
tent of denudedsurfacearea for each region. For example theTable
Prevalence and size (%) of de
Location No. (%) of participants with
denuded area at baseline
Size (%
in in
n
Femur 70 (46.7) 35
Lat Tibia 17 (11.3) 9
Med Tibia 35 (23.3) 18
Patella 59 (39.3) 30
Trochlea 53 (35.3) 27
Cent Lat Femur 16 (10.7) 8
Cent Lat Tibia 11 (7.3) 6
Cent Med Femur 55 (36.7) 28
Cent Med Tibia 38 (25.3) 19
Post Med Femur 20 (13.3) 10
cþ p Med Femur 47 (31.3) 24
Cent Med Fþ T 47 (31.3) 24mean change in cartilage volume for whole sample (N¼ 150)
for the central medial femurwas39.1 (SD 99.5)mm3, which
givesanSRMof0.39. In thesubsampleof kneeswith node-
nuded area the SRMwas0.38, in the knees with intermedi-
ate denuded area (n¼ 28) the SRMwas0.33, and in knees
with severe denuded area (n¼ 27) the SRM was 0.55. For
normalized volumeof the centralmedial femur in the subsam-
ple of kneeswith no denudedarea theSRMwas0.33, in the
kneeswith intermediate denuded area (n¼ 28) the SRMwas
0.40, and in knees with severe denuded area (n¼ 27) the
SRM was 0.54. For the combined central medial femur
and tibia the mean volume change for the whole sample
was 48.2 (SD 159.8) mm3, which gives an SRM of0.30.
For cartilage volume of the subsample of knees with no de-
nuded area the SRMwas0.25, in the knees with intermedi-
ate denuded area (n¼ 24) the SRMwas0.30, and in knees
with severe denuded area (n¼ 23) the SRM was 1.00. For
normalized volumeof the centralmedial femur in the subsam-
ple of kneeswith no denudedarea theSRMwas0.22, in the
kneeswith intermediate denuded area (n¼ 24) the SRMwas
0.26, and in knees with severe denuded area (n¼ 23) the
SRM was 0.71. The magnitude of the SRMs varied across
the different locations in the knee and was generally smaller
in participants with no denuded surface area at baseline. In
contrast the SRMs in participants with denuded area had
SRMsof largermagnitude. The subsampleswith the greatest
responsiveness were those with severe denuded surface
area in the combined central medial femur and tibia which
had SRMs of 1.00 for cartilage volume and 0.71 for nor-
malized cartilage volume. The predominant compartment af-
fected by OA and the enrichment used for this subsample
focused upon medial tibio-femoral OA. Somewhat surpris-
ingly the SRMs for the severe denuded area sample for the
central lateral tibia and central lateral femur also exceeded
0.7. Consistent with our initial hypothesis the SRMs in-
creased from the no denuded surface area to the severe de-
nuded area for the central medial femur and central medial
tibia and their combination. In general the intermediate de-
nuded surface area group showed intermediate values.
We performed further analyses (data not shown) to as-
certain if it is worth combining the intermediate and severe
denuded surface areas into one group. The SRMs in partic-
ipants with any denuded areas were larger than those with-
out denuded areas. For example the mean change of
normalized cartilage volume trimmed was signiﬁcantly dif-
ferent between two groups at lateral tibia (P¼ 0.0173), cen-
tral lateral tibia (P¼ 0.0005) and central medial tibia
(P¼ 0.0044). If the results for the SRMs were comparedI
nuded area at baseline
) of denuded area
termediate group
Size (%) of denuded area
in severe group
Mean (SD) n Mean (SD)
0.040 (0.019) 35 0.112 (0.040)
0.020 (0.009) 8 0.104 (0.113)
0.119 (0.049) 17 0.454 (0.533)
0.050 (0.041) 29 1.172 (2.162)
0.043 (0.043) 26 0.344 (0.190)
0.015 (0.004) 8 0.109 (0.070)
0.027 (0.010) 5 0.157 (0.184)
0.068 (0.065) 27 1.057 (1.079)
0.156 (0.093) 19 0.878 (1.211)
0.031 (0.021) 10 0.160 (0.092)
0.066 (0.052) 23 0.375 (0.196)
0.112 (0.089) 23 0.842 (0.719)
Table II
Cartilage volume trimmed (mm3): baseline value, annualized mean change and SRM for this change, annualized percent change,
annualized mean change group by denuded surface area. N¼ 150
Baseline
mean (SD)
Mean change
(SD) from model
SRM for mean
change (95% CI)
Percent
change (SD)
No denuded surface area Intermediate denuded surface area Severe denuded surface area
Mean
change (SD)
SRM
(95%CI)
Mean
change (SD)
SRM
(95%CI)
Mean
change (SD)
SRM
(95%CI)
Femur 12031.9 (3224.0) 19.7 (325.8) 0.06 (0.24, 0.10) 0.12 (3.02) 33.1 (318.8) 0.10 (0.13, 0.31) 78.2 (357.4) 0.22 (0.61, 0.11) 81.8 (295.1) 0.28 (0.70, 0.08)
Lat Tibia 2272.1 (733.0) 18.7 (76.7) 0.24 (0.40, 0.09) 0.98 (4.63) 18.0 (74.5) 0.24 (0.41, 0.08) 11.9 (103.1) 0.12 (1.25, 0.66) 37.7 (89.7) 0.42 (1.78, 0.30)
Med Tibia* 1996.6 (642.6) 6.5 (98.8) 0.07 (0.22, 0.09) 0.28 (5.24) 1.9 (99.2) 0.02 (0.17, 0.21) 59.8 (106.3) 0.56 (1.43, 0.05) 6.8 (71.5) 0.10 (0.63, 0.43)
Patella 2726.7 (1212.6) 33.5 (134.3) 0.23 (0.42, 0.08) 1.67 (7.48) 18.5 (134.3) 0.14 (0.36, 0.07) 64.2 (162.4) 0.40 (0.75, 0.06) 49.5 (91.9) 0.54 (1.10, 0.16)
Trochlea 4571.7 (1473.8) 4.4 (193.6) 0.02 (0.14, 0.18) 0.05 (4.68) 29.2 (204.7) 0.14 (0.06, 0.37) 35.7 (180.6) 0.20 (0.69, 0.20) 46.7 (147.8) 0.32 (0.82, 0.10)
Cent
Lat Femur
1751.7 (556.1) 2.5 (63.6) 0.04 (0.21, 0.12) 0.07 (3.75) 0.67 (64.3) 0.01 (0.17, 0.18) 13.1 (43.4) 0.30 (2.21, 0.45) 44.4 (58.6) 0.76 (2.69, 0.18)
Cent
Lat Tibia
1892.0 (608.6) 16.5 (69.1) 0.24 (0.39, 0.09) 1.12 (5.25) 13.7 (68.2) 0.20 (0.36, 0.05) 32.5 (75.9) 0.43 (3.43, 0.50) 74.9 (71.3) 1.05 (3.61, 0.78)
Cent
Med Femur
1509.5 (711.2) 39.1 (99.5) 0.39 (0.53, 0.26) 2.93 (9.75) 40.6 (104.5) 0.38 (0.57, 0.23) 35.5 (108.8) 0.33 (0.61, 0.005) 37.3 (67.8) 0.55 (1.14, 0.15)
Cent
Med Tibia
1320.9 (505.7) 9.5 (82.5) 0.12 (0.26, 0.04) 0.83 (7.26) 0.52 (80.6) 0.01 (0.19, 0.18) 44.4 (106.7) 0.42 (0.95, 0.01) 27.2 (53.2) 0.51 (1.17, 0.06)
Post
Med Femur
1741.9 (498.0) 1.4 (76.3) 0.02 (0.19, 0.16) 0.12 (5.11) 3.1 (76.6) 0.04 (0.22, 0.15) 29.4 (95.7) 0.31 (0.36, 1.20) 9.2 (42.5) 0.22 (1.18, 0.56)
cþ p
Med Femur
3251.3 (1103.8) 40.01 (134.2) 0.30 (0.47, 0.13) 1.18 (4.70) 38.9 (134.2) 0.29 (0.47, 0.10) 42.9 (155.5) 0.28 (0.71, 0.13) 42.2 (112.3) 0.37 (0.97, 0.07)
Cent
Med Fþ T
2830.3 (1183.0) 48.2 (159.8) 0.30 (0.45, 0.15) 1.99 (6.75) 39.1 (158.8) 0.25 (0.43, 0.06) 62.7 (212.0) 0.30 (0.63, 0.10) 76.0 (76.3) 1.00 (1.68, 0.53)
*MT: Overall comparison, P-value is signiﬁcant with P¼ 0.0472; no vs moderate denude area, P¼ 0.0361.
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181Osteoarthritis and Cartilage Vol. 18, No. 2with those in Tables II and III there does appear to be higher
SRMs in the severe denuded surface area group compared
to the composite group of intermediate and severe. Thus we
continued the focus of presenting the intermediate and se-
vere as distinct groups. We also examined the relation of
denuded area in the adjacent plate and the effect of carti-
lage loss in the plate adjacent. For example if lateral tibial
plate has denuded area the plate adjacent (lateral femur)
is also at greater risk for cartilage loss. In general the mag-
nitude of these changes in the adjacent plate was not as
great as those in the local plate (site-speciﬁc) when a de-
nuded area was present.
We also examined whether age and BMI was related to
the presence of denuded area. Those with denuded area
were generally somewhat older than those without denuded
area (Table IV). However, BMI does not appear to be re-
lated to the presence of denuded area.Discussion
Efforts are being made to enhance identiﬁcation of partici-
pants with knee OA most likely to progress in clinical trials.
This study demonstrates that by selecting participants and re-
gionswith the presence of a full thickness cartilage defect (de-
nuded area) the ability to demonstrate change in cartilage loss
in that plate is improved. Using this option for screening during
recruitment in clinical trials could facilitate the detection of par-
ticipants at greater risk of subsequent cartilage loss. Consis-
tent with prior studies8,10,12,26 the individual region with the
largest magnitude of change appears to be the central medial
femur. The combined cartilage volumes of the central medial
femurandcentralmedial tibia in thesubsamplewithseverede-
nuded area provided the most responsiveness.
These ﬁndings of cartilage loss occurring in regionswith al-
ready denuded area are consistent with theories that suggest
full thickness lossmay be the ﬁrstmeasurable change inmor-
phometry rather than diffuse thinning27. In early OA cartilage
may not be thin but rather thicker and swollen with water,
which is imbibed by cartilage when the collagen network is
disrupted and the role of proteoglycans is altered28e31. Previ-
ous studies have suggested that the initial pathology includes
cartilage thickening, and it is not clearly understood if it repre-
sents an initial reversible phenomenon, permanent tissue
damage or if it is the expression of a reparative process32.
This may explain the lack of responsiveness of the traditional
methodsofmeasuring cartilage volume in large regions of the
knee (e.g., medial tibia) and regional mean thickness as dis-
tinct from focal measures of change (region of interest analy-
sis centered around focal defects33), as it is likely that large
regionswill encapsulate regions that are swollen. By focusing
attention on smaller regions and those that already have a full
thickness defect the opportunity to measure change is maxi-
mized. This is consistent with suggestions that cartilage de-
fects measured semi-quantitatively may occur in early knee
OA and precede cartilage volume loss18,19.
Our own data fromOAI showing conservative cartilage vol-
ume loss of about 1 to 3% per year8 conﬁrms ﬁndings in
other studies including Mechanical Factors in Arthritis of the
Knee (MAK)10, Pﬁzer26 and more recently data by Eckstein
and colleagues from OAI12. These small rates of change
have important implications for clinical trial planning of dis-
ease modifying treatments for OA using MRI techniques
that could be enhanced by the results of this study. Whilst it
is inherently appealing to identify participants at greatest
risk for progression, this methodology would include acquisi-
tion and processing of an MRI during the screening process
Table IV
Relation of age and BMI to presence and absence of denuded areas
Location Age in years BMI (kg/m2)
W/o denuded surface
area
W/denuded surface
area
P-value W/o denuded surface
area
W/denuded surface
area
P-value
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Femur 60 (9.7) 64 (9.8) 0.0116 30.7 (4.8) 29.9 (4.6) 0.3389
Lat Tibia 62 (9.9) 60 (10.2) 0.4604 30.2 (4.7) 31.1 (4.4) 0.4799
Med Tibia 61 (9.8) 66 (9.3) 0.0044 30.4 (5.0) 30.1 (3.6) 0.7570
Patella 61 (9.9) 64 (9.6) 0.0391 30.1 (4.6) 30.6 (4.8) 0.5083
Trochlea 62 (10.0) 62 (9.9) 0.5997 29.9 (4.6) 31.0 (4.8) 0.1954
Cent Lat Femur 62 (9.9) 63 (10.2) 0.6066 30.2 (4.4) 31.0 (7.0) 0.6613
Cent Lat Tibia 62 (10.0) 58 (8.6) 0.1849 30.3 (4.7) 30.0 (4.9) 0.8020
Cent Med Femur 60 (9.8) 65 (9.5) 0.0105 30.0 (4.7) 30.8 (4.7) 0.3082
Cent Med Tibia 61 (9.8) 66 (9.2) 0.0046 30.4 (5.0) 30.1 (3.9) 0.7499
Post Med Femur 61 (9.9) 65 (9.7) 0.0866 30.3 (4.8) 30.2 (3.9) 0.9262
cþ p Med Femur 61 (10.0) 65 (9.1) 0.0152 30.2 (4.7) 30.6 (4.7) 0.5793
Cent Med Fþ T 60 (10.0) 65 (8.8) 0.0055 30.2 (4.7) 30.6 (4.7) 0.5640
182 D. J. Hunter et al.: Region of interest analysiswith implications for participant burden and cost. If the central
medial femur were chosen as the region of interest only 37%
of the OAI progression cohort participants (based upon this
subsample) will have a focal defect in this region with implicit
impact on the screen failure rate. The upside is enhanced
study efﬁciency and using amethod with improved predictive
value for detecting progression. As has been seen from prior
studies there is marked heterogeneity in results of respon-
siveness for cartilage morphometry. This risk stratiﬁcation
method may also work when other cartilage segmentation
techniques are used however, this needs to be formally
assessed and these results replicated.
One caveat to this risk stratiﬁcation methodology is that
while one can identify knees with more rapid cartilage
loss, it does not mean that these knees are optimal candi-
dates for a clinical trial. If the pathological changes of carti-
lage loss are irreversible, and attention is focused on those
at the end stage of the disease one may not be able to ac-
complish our goal of modifying the progress of the condition
as a drug may not produce cartilage in the denuded area.
This study has several limitations. The automated, pairwise
imagesegmentationprocessused imposesabiasoncartilage
thickness and volumemeasurements, and is a unique feature
of our methodology. Paired image analysis is typically more
precise than unpaired image analysis, and biases imposed
by these processes need to be presented and accounted for
analysis. The relative advantages of our analysis methods
will require independent segmentation and quantiﬁcation of
these images by alternative image analysis techniques.
The separation of the cartilage tissue into several com-
partments introduces noise into the region of interest mea-
surements. Without this subdivision it is impossible to report
localized changes and therefore the ability to detect
changes will be minimized. On the other hand, the segmen-
tation of cartilage plates was done using an automated pro-
cess that only increases marginally the measurement error.
The original description of the KeL grade was made and
developed on weight bearing, fully extended ﬁlms not on
ﬁlms acquired semi-ﬂexed such as in this study.
In conclusion, this study demonstrates that by selecting
participants with the presence of a severe full thickness car-
tilage lesions the ability to demonstrate change in cartilage
loss in that speciﬁc location is markedly improved com-
pared to persons without a full thickness lesion in that
cartilage plate. This option for screening during recruitment
in clinical trials could facilitate the detection of participants
at greater risk of subsequent cartilage loss.Conﬂict of interest
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